Pancreatitis, Chronic Clinical Trial
— IMPACTOfficial title:
Development and Feasibility Testing of an Internet-based Pain Self-management Program for Persons With Acute Recurrent and Chronic Pancreatitis Pain (The IMPACT Study)
Verified date | September 2021 |
Source | Seattle Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pain is the cardinal symptom of acute recurrent and chronic pancreatitis, and available medical treatments have limited efficacy. Pain self-management programs equip patients to minimize the impact of chronic painful conditions on activity, health, and psychosocial functioning. The purpose of the current study is to pilot the use of Internet-delivered pain self-management course in adults with chronic and acute recurrent pancreatitis to generate preliminary feasibility and acceptability data to inform design of a subsequent large randomized controlled trial.
Status | Completed |
Enrollment | 32 |
Est. completion date | September 30, 2020 |
Est. primary completion date | September 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age = 18 years 2. Able and willing to provide informed consent for participation in this study 3. Meet CPDPC criteria for diagnosis of either suspected CP (CPDPC "yellow zone") or definite CP (CPDPC "red zone") 4. Have personal internet access on any device (e.g., phone, tablet, computer) 5. Has experienced pain intensity rated as 4 or higher on a 0-10 scale in the last month Exclusion Criteria: 1. Currently undergoing treatment for cancer 2. Inability to understand English well enough to complete questionnaires or to participate in treatment 3. Severe depression (i.e., indicated by a score > 22 on the Patient Health Questionnaire (PHQ-9) 4. Significant suicidal ideation (i.e., indicated by a score > 2 to Question 9 of the PHQ-9) 5. Acutely suicidal or recent history of attempted suicide or self-harm (i.e., last 12 months) 6. Currently receiving treatment with a psychologist |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Seattle Children's Hospital | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Ohio State University, University of Pittsburgh Medical Center |
United States,
Palermo TM, Law EF, Topazian MD, Slack K, Dear BF, Ko YJ, Vege SS, Fogel E, Trikudanathan G, Andersen DK, Conwell DL, Yadav D; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Internet Cognitive-Behavioral Therapy — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Treatment acceptability | Participants will complete a 12-item Treatment Evaluation Inventory questionnaire that assesses satisfaction and acceptability of the course of treatment and satisfaction with the outcome of the intervention. Items are rated on a 5-point Likert scale ranging from 1 = Strongly disagree, to 5 = Strongly agree. | Immediately post-treatment | |
Secondary | Treatment feasibility | Feasibility will be determined by calculating rates of accrual, drop out, compliance, and missing data. Criteria for feasibility success will be based on: accrual rates >70%, attrition rates <15%, minimal technical difficulties (i.e., reported by <10%), adherence rates >80%, and minimal missing data. | Immediately post-treatment | |
Secondary | Change in pain intensity | Participants will report on presence and intensity of pain daily for 7 days at each assessment period. Pain intensity will be assessed using an 11-point numerical rating scale (NRS), where 0= no pain, and 10 = worst pain. Mean average intensity of the pain reported will serve as the pain measure. | Baseline, 3-month follow-up | |
Secondary | Change in pain-related disability | Participants will report their level of pain-related disability daily for 7 days at each assessment period. Questions of pain-related disability are taken from the Brief Pain Inventory and the Pain Disability Index. These measures assess the extent to which chronic pain disrupts aspects of daily life including social relations, work, mood, sleep, eating, and physical activity. All items are scored on a 0-10 NRS, with higher scores indicating greater disability. | Baseline, 3-month follow-up | |
Secondary | Change in Disease specific and generic health related quality of life (HRQOL) | Participants will complete the 18-item Pancreatitis Quality of Life Instrument to assess for disease-specific HRQOL difficulties. Items are scored on a 0-5 scale where 0 = Not applicable, 1 = Much less, and 5 = Much more. Participants will also complete the 12-item Short-Form Health Survey to assess for general HRQOL. | Baseline, 3-month follow-up | |
Secondary | Change in Medication use | Participants will record their medication use daily for 7 days at each assessment period | Baseline, 3-month follow-up | |
Secondary | Change in Pain self-efficacy | Participants will complete the 4-item Chronic Pain Self-Efficacy Scale. This scale assesses perceived self-efficacy over three factors: pain management, coping with symptoms, and physical function. All items are scored on a 7-point Likert scale where 0 = Not at all confident, and 6 = Completely confident | Baseline, 3-month follow-up | |
Secondary | Change in Psychological distress | Participants will complete the 4-item Anxiety and 4-item Depression subscales of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile to assess for levels of psychological distress over the past week. Items are scored on a 5-point Likert scale ranging from 1 = Never, to 5 = Always. | Baseline, 3-month follow-up | |
Secondary | Change in Sleep and Fatigue | Participants will complete the 4-item Sleep Disturbance and 4-item Fatigue subscales of the PROMIS-29 Profile to assess for problems with fatigue and sleep over the previous week. All items are scored on a 5-point Likert scale ranging 1 = Not at all, to 5 = Very much, except for one sleep item which is scored 1 = very poor, to 5 = Very good. | Baseline, 3-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05326542 -
Comparison of Efficacy of ESWL and Laser Lithotripsy in Chronic Pancreatitis With ERCP
|
N/A | |
Completed |
NCT01731821 -
Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy
|
Phase 3 | |
Completed |
NCT01551511 -
Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain
|
Phase 2 | |
Active, not recruiting |
NCT05095831 -
EUS Shear Wave for Solid Pancreatic Lesions.
|
||
Completed |
NCT03173118 -
Elastography in the Diagnosis of Chronic Pancreatitis
|
N/A | |
Terminated |
NCT01318590 -
Prospective Study on Endoscopic Ultrasound (EUS) Celiac Bloc Efficacy in Chronic Pancreatitis
|
Phase 3 | |
Recruiting |
NCT05772234 -
Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis
|
N/A | |
Recruiting |
NCT04131010 -
Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis
|
N/A | |
Terminated |
NCT00359320 -
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT02940067 -
Enhancing Fitness Before Pancreatic Surgery
|
N/A | |
Recruiting |
NCT05261997 -
Endotherapy for Painless Chronic Pancreatitis
|
N/A | |
Not yet recruiting |
NCT05270434 -
Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.
|
N/A | |
Completed |
NCT03672422 -
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
|
||
Enrolling by invitation |
NCT05287737 -
Clinical Outcome After Total Pancreatectomy With Islet Autotransplantation
|
||
Not yet recruiting |
NCT06426160 -
Tocilizumab for Painful Chronic Pancreatitis
|
Phase 2 | |
Enrolling by invitation |
NCT05289362 -
Comparison of Efficacy of Basket and Balloon in the Removal of Pancreatic Duct Stones in Chronic Pancreatitis Under ERCP
|
N/A | |
Not yet recruiting |
NCT04760847 -
Intermittent Fasting for Pancreatitis
|
N/A | |
Enrolling by invitation |
NCT03228095 -
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
|
||
Completed |
NCT00956839 -
Prospective Study of Efficacy of Intra-muscular Vitamin D3 in Tropical Calcific Pancreatitis
|
Phase 4 | |
Completed |
NCT00676702 -
A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)
|
Phase 1 |